Clinical Trial Update: A Clinical Study for Validating the Equivalence of Bloomlife MFM-Pro to Clinical Standard-of-care for Performing Antepartum Fetal Monitoring [NA]

View source ↗

Summary

A completed clinical trial validating equivalence of Bloomlife MFM-Pro to standard-of-care for antepartum fetal monitoring; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Monitoring

Drugs mentioned

• Bloomlife MFM-Pro

Snippet

Sponsor: Bloom Technologies | Conditions: Fetal Monitoring | NA | Status: COMPLETED | Results posted: 2023-10-18